Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Brand awareness, and it's definitely paying off!!!
Bate, hopefully you are right, what is completely certain is that we elected a great company at an early stage and that is every investor's dream. I have all the patience in the world and trust me, I will be here for many years to come(if God allows me to be here).
Next year we will capture new customers in allergy season and when you add them to the ones who already tried us you have a grand slam (our Fluticare reviews are unbelievable so no reason for them to switch to another brand).
Fiji awaits us.
almost a million shares in half an hour, holy s***t
guys, remember this is an estimate, so basically the market takes it as a rumor and you know the saying, buy the rumor sale the news, we are going to have 25 days of buying until we get the actual press release, I'm pretty sure lots of us want to buy but the funds won't clear until later this week, I think we will get to .20 to .30 before the actual press release. Good luck to you all
A few months ago I said buying INNV was like buying Johnson and Johnson at an early stage... I believe that statement to be more accurate now than ever.
Today should be a very interesting day for INNV Chris20, and in my opinion the stock is extremely undervalued.
(((EARNINGS-NEWS-OUT)))-Preliminary-Q2-2018-Sales-Revenue-of-$6.6-million-to-$6.8-million
Business Wire•July 17, 2018
SAN DIEGO--(BUSINESS WIRE)--
Preliminary Quarterly Revenue Increase of 47-51% and Comparable 2017 Second Quarter Increase of 330-340% and Fiscal Year 2018 Net Revenue Annual Guidance Adjusted Upwards to at Least $22 Million
Innovus Pharmaceuticals, Inc., (“Innovus Pharma”) (INNV), today announced preliminary second quarter 2018 net revenue is estimated to be between $6.6 million to $6.8 million or an approximate 47-51% increase from the first quarter of 2018 and an approximate increase of 330-340% from the second quarter of 2017. Innovus Pharma's second quarter 2018 anticipated revenue results are preliminary and based on the most current information available and are subject to completion of the condensed consolidated financial statements for the second quarter of 2018, which are to be filed with the SEC no later than August 14, 2018.
“We are seeing exceptional growth in our sales channels, additional markets and product pipeline which now stands at 32 products in the United States and overall net revenue growth during 2018 with our estimated second quarter net revenue of between $6.6 million to $6.8 million. Because of our continued strong growth, we have adjusted our 2018 annual revenue guidance from $18 million to at least $22 million. We believe our revenue growth into 2018 highlights the continued strength of our ability to sell multiple products and increase the sales channels through our Beyond Human™ sales and marketing platform, direct mailing, e-commerce sites and other sales channels,” stated Bassam Damaj, President and Chief Executive Officer of Innovus Pharma. “We also continue to work hard towards our goal of profitability.”
About Innovus Pharmaceuticals, Inc.
Headquartered in San Diego, Innovus Pharma is an emerging OTC consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases. Innovus Pharma delivers innovative and uniquely presented and packaged health solutions through its (a) OTC medicines and consumer and health products, which we market directly, (b) commercial partners to primary care physicians, urologists, gynecologists and therapists, and (c) directly to consumers through our on-line channels, retailers and wholesalers. The Company is dedicated to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application (“ANDA”) products. The Company is actively pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (or Rx) to OTC.
For more information, go to www.innovuspharma.com; www.zestra.com; www.ejectdelay.com; www.myvesele.com; www.urivarx.com; www.sensumplus.com; www.myandroferti.com; www.beyondhumantestosterone.com; www.getbeyondhuman.com; www.trybeyondhuman.com; www.recalmax.com; www.prostagorx.com; www.fluticare.com; www.allervarx.com; and www.apeaz.com.
* Population data for Florida and Texas gathered from the 2010 Census Brief from the United States Census Bureau.
Innovus Pharma’s Forward-Looking Safe Harbor
Statements under the Private Securities Litigation Reform Act, as amended: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risks and uncertainties that may individually or mutually impact the matters herein described for a variety of reasons that are outside the control of the Company, including, but not limited to, its financial results, projected revenues, projected online subscribers and other customers, estimated markets for its products, and statements about achieving its other corporate and business development, growth, commercialization, financial and staffing objectives. Readers are cautioned not to place undue reliance on these forward-looking statements as actual results could differ materially from the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's most recent filing on Form S-1, annual report on Form 10-K, subsequent quarterly reports filed on Form 10-Q and other filings made with the SEC. Copies of these reports are available from the SEC's website or without charge from the Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180717005313/en/
Contact:
Innovus Pharma Investor Relations
Randy Berholtz, +1 858 249 7865
ir@innovuspharma.com
INNOVUS is doing it's job guys, now is our turn, spread the word, talk to family members, friends, coworkers etc, they will thank you, your stock will rise and you will be their hero!!!
BOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM
The news of the day is this one: THE STOCK IS ALIVE. We just had over 2 million shares traded today. MM know they still have a month to use their scare tactics to grab cheap stocks and they will squeeze everything they can out of that time. Keep a strategy, buy when you feel the stock is cheap, nothing is stoping this stock's success. JMHO.
We need 4.3 million in sales for 2Q to match the entire 2017 in just 6 months.
You are right, I gave him to much credit for something as simple as criticism.
What a waste of talent, unfortunately I won't see you at the top, I've never seen a statue being built for a critic, only the builders and creators get the honor.
True trades, you have such a great potential and I'm pretty sure you are doing good, but I feel your potential could do a lot more than to destroy a small company; with your will, your research capacity and your ability to write smart comments you could really help a small company grow exponentially, the sky is the limit. This tiny company is valued at a mere 20 million dollars and is fighting face to face against billion dollar giants in the market and believe it or not we are gaining ground every day. Think about us going from being a 20M to a Billion, that would be a 50X hit. A 20K investment would make you a millionaire. I believe is doable and I know at the bottom you know it too. Doesn't require a genius to destroy something, the challenge is in building something from the ground up and I know you have the ability to build it!!!
BOOOOOOOM!!!!
Guys, it's official, for the first time (as far as I know) we are in the top 20 in AMAZON.
https://www.amazon.com/Best-Sellers-Health-Personal-Care-Allergy-Medicine/zgbs/hpc/3760991
January is still their rainy season, it's better to wait until May when precipitations decrease dramatically.
In my opinion all this stock needs is an internal purchase of a million plus shares and the PPS will go all the way to a buck in a day. With the way the company is doing I can totally see this scenario as a huge possibility.
I'll see you at the top.
We are currently the 24th best seller in Amazon out of more than 2100 items under allergy. 2 months ago we were lucky to be in the top 100, now we have gained a spot in the top 30. Next year we are not going to be the new kids in the block, lots of people will look for us by name. I love this company!!!!
I visited 5 cities while in Russia, Moscow, Saransk, Saint Petersburg, Samara and Kazan and I can tell you I had a great experience everywhere; people was very friendly and helpful, the food is amazing, Moscow, Saint Petersburg and Kazan are very beautiful cities with European and middle eastern influence and yet very americanized; you can find a lot of american chains everywhere, american vehicles, american music etc. On topic, I really hope Innv gives you everything you are waiting for, it's a great company so I see no reason for your strategy to fail.
It should be an interesting match tuesday, let's see what happens!
With INNV I'm planning to keep adding, I really feel this is the train I've being waiting for all my life and I'm not letting it go. I think dollarland will come soon enough but I feel this company is a lot more than that.
I was Batemere, I went to Colombia's 3 first games and the Argentina Vs Nigeria, but I'm back in the USA now. Got to take care of business. That's the reason I haven't being as active as usual in the chat but I see the new developments with lots of optimism.In my honest opinion this is the best company to be invested on, no question about it, I know as investors we want to see our money grow fast and that hasn't being the case but take that as a great oportunity to lower your cost per share and accumulate as many shares as possible. We are a real company, with real products, doing some real sales and expanding globally, what else can we ask
for!!!
We are #30 right now, it's 10:15 am Moscow time!!!
I love this company, just added 100.000 shares to my collection. :)
great Rankings, I still think the mos impresive of them all is being 32 in the allergy product since it contains more than 1900 items and we have being competing in Amazon for less than 7 months... yeah baby!!!
https://www.amazon.com/Best-Sellers-Health-Personal-Care-Allergy-Medicine/zgbs/hpc/3760991
We are number 33 right now at Amazon, our best position as far as I know.
We just need a hint of this quarter's numbers (anything above 4.5 million) and the stock should fly.
JMHO
This is my point of view and please do your own DD before investing but I truly believe the stock is being manipulated by MM so they can grab as many cheap shares as possible from a business that is booming and is as transparent as crystal, just think about this, we are trading a pink sheet, this is not being looked closely by any entity since they don't have the man power to do it, however INNV tells you we are not profitable yet even when they know that's exactly what everyone wants to hear to send this stock to the moon, they report to the SEC as regularly as a Nasdaq company, they have external audits etc... so transparency is there every step of the way but they are not only transparent, they have being able to increase sales 3 years in a row and one of the biggest worries some of you have "we don't have the ANDA" is not a bad thing, is actually a great thing if you look at the future this company has, if we are able to sell $4.5 million without brick and mortar sells, imagine what we can achieve once we get it, trust me, MM know that and they are eager to buy your cheap shares because this stock is going to go crazy in the near future. BUY BUY BUY and HOLD!!!
You finally got it, it's a projection, no one owns the future an predicting it is imposible unless you are Mrs Cleo (lol), however you can project numbers into the future by doing simple math. 4.5 millions in one quarter multiplied by 4 quarters in a year = 18 million. The next 3 quarters could be lower or higher but common sense indicates that they will be higher because it's allergy season and new products are captivating new customers and getting repeated business, but hey, who I am to predict that.
please enlighten us with your prediction for the year.
Great job stephen218, that what DD is all about. In a few minutes we will have TT and the depresing guys trying to discredit this information like they know more or have better credibility than Zacks investment research or Valuengine.
Hey Bate, you only lose if you sale at a loss and, honestely your comments will not help your stocks go higher. You are way smarter than this Bate, don't let your emotions guide you. The good days are comming, just have patience and we will celebrate together. Have a great day my friend!!!
JMHO.
I agree with you, the company doubled it's sales in 2017 with 8.8 millions sold; in the first quarter of 2018 they sold 4.5 million, that's more than half of what we sold in the entire year of 2017. We just got clearance to commercialize 2 new products in Canada and the company is investing heavily to create brand awarness. Our CEO owns 12.5% of all outstanding shares and most of our officers get compensantion in company shares which tells me they believe in the company. In my opinion this is a no brainer!!
PPS goes up and down, that's part of the trade, the company is growing, sales are increasing and the brand is getting renown, you don't need to be a visionary to know we have a great company in our hands and no one is more invested in it that our CEO. Good luck to all and patience, I've being in this position many many times and a good company always ends up going up!!!
JMHO.
easy, how many shares do you own? i'll buy them all at .12 cents a piece and get lost. You don't like my deal? you are a shorter!!!! next!!!!
Do you want a Fact?
true trades makes 10 comments per day, times 90 days in a quarter makes 900 comments per quarter, Innovus sales 4.5 million dollars per quarter so basically Innovus sales 5000 dollars every time true trades makes one of his toxic comments. Kaboooooooom!!!
Gi,
I don't pay attention to trivialities and assumptions, I pay attention to growth and potential. if you need to talk about trivialities and assumption please create a chat with true trades and the toxic group, I don't want anything interfering my chi!!!
Well, just the fact that he personally own 12.5% of the company tells me he is going to do everything within his power to bring the value of this company up. Sales are growing at an unprecedented rate and we are competing hand to hand with multi billion dollar companies in their field of expertise. I wouldn't be surprised at all if INNV gets to half a billion dollars in valuation in the next 2 to 5 years.
Wouldn't you agree that Dr Damaj owning 23 million shares of the company makes the R/S theory completely absurd? who in their right mind will do something to hurt their own finances that much? and if they do it, it will be when the company is strong enough to be uplisted to nasdaq which in fact will be a great move instead of something negative as the 3 stooges claim. When you go to a lake it's your decision if you want to bathe with it's crystal waters or get dirty with the mud. This chat contains a lot of honest information and also contains BS that brings doubts and lies, it's our choice which we pay attention to!!
Thank you Drugdoctor for being a light in this journey.
Another refreshment:
Dr. Damaj owns $23.7M shares.
Our CEO is the person who has the most to lose if we don't go up.